Showing results (1071-1080 of 5,585) with videos related to

Sort By:
Pageof 559
Nuclear Medicine Communications|October 7, 2015
Correlation between early 18F-FDG PET/CT response to BRAF and MEK inhibition and survival in patients with BRAF-mutant metastatic melanomaRonald J Schmitt, Sarah M Kreidler, Deborah H Glueck, et al.
Nuclear Medicine Communications|August 28, 2015
Effects of myocardial perfusion abnormalities on the accuracy of left ventricular volume and ejection fraction measured by thallium-201 gated single-photon emission tomography: comparison with echocardiography as the reference standardSatoshi Kurisu, Toshitaka Iwasaki, Nobukazu Abe, et al.
Nuclear Medicine Communications|August 25, 2015
Reducing CT dose in myocardial perfusion SPECT/CTEmma O'Shaughnessy, Kat L Dixon
Nuclear Medicine Communications|August 25, 2015
Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy in a real-life scenarioAlfredo Campennì, Luca Giovanella, Salvatore A Pignata, et al.
Nuclear Medicine Communications|August 25, 2015
The relative value of 18F-FDG PET interpretation criteria in generating a probabilistic approach for characterization of pulmonary nodulesAnna Danilenko, Mathieu Charest, Antoine Leblond
Nuclear Medicine Communications|December 1, 1989
A new, simple and precise method for the determination of right ventricule forward ejection fraction in first-pass radionuclide cardiographyO Carlsen
Nuclear Medicine Communications|November 1, 1989
Early effects of intra-arterial chemotherapy in patients with brain tumours studied with PET: preliminary resultsK J Langen, N Roosen, T Kuwert, et al.
Nuclear Medicine Communications|October 29, 2014
Comparison between low and high radioactive iodine (131I) reablation dose in patients with papillary thyroid cancerSherif M El-Refaei, Shereen W Yassin, Khaled Salman, et al.
Nuclear Medicine Communications|December 1, 1989
99Tcm(v)-DMSA planar scintigraphy: does it have a role in the management of patients with head and neck squamous carcinoma?J C Watkinson, C R Lazarus, M N Maisey, et al.
Nuclear Medicine Communications|January 21, 2015
Response criteria for malignant lymphomaAnna M Maffione, Rossella Paolini, Elisabetta Rodella, et al.
Pageof 559